The detailed molecular mechanisms contributing to long-term narrowing of the cerebral artery in vasospasm are a topic of intense experimental study. In experimental vasospasm, J-L-calpain-but not m-calpain-was continu ously activated in the canine basilar artery (Yam aura et aI., 1993; Sato et aI., 1997) , suggestive of a continuous increase in intracellular Ca 2 + levels in vasospasm. On the other hand, J-L-calpain was transiently activated only in the beginning of vasocontraction induced by KCI or se rotonin. Increased intracellular Ca 2 + levels may activate Ca 2 +/calmodulin-dependent myosin light chain kinase (MLCK) in smooth muscle to phosphorylate myosin light chain (MLC). This regulatory pathway of Ca 2 +_ calmodulin-MLCK is the major potential feature of con tractile system regulation in smooth muscle. Recently, vasospasm of canine anterior spinal artery has been re ported to be associated with an increased phosphoryla tion of MLC (Butler, et aI., 1996) . The canine vasospasm was significantly reversed by a topical application of 1-(5-chloronaphthalenesulfonyl)-I H-hexa-hydro-l ,4-diazepine (Kokubu et aI., 1989) , a selective MLCK in hibitor, suggestive of the involvement of MLCK in de velopment of vasospasm. In addition, smooth muscle PPl , which dephosphorylates MLC (Alessi et aI., 1992) , was decreased in activity in vasospasm (Fukami et aI., 1995) . Much attention has been paid to phosphorylation dephosphorylation of thin-filament proteins calponin (CaP) and caldesmon as the second potential feature of contractile system regulation. Calponin inhibits the actin activated Mg 2 + -ATPase activity of smooth muscle through its binding to actin in vitro (Takahashi et aI., 1986; Winder and Walsh, 1990; Naka et aI., 1990) , and the inhibitory effect of CaP is alleviated by phosphory lation catalyzed by protein kinase C (PKC) and calmod ulin kinase II in vitro (Winder and Walsh, 1990; Naka et aI., 1990; Horowitz et aI., 1996b) . The mechanism of involvement of PKC in vasospasm remains controver sial, but we have demonstrated the activation of PKCa and the formation of protein kinase M (PKM), catalytic fragment of PKCa, in vasospasm (Minami et aI., 1992; Sato et aI., 1997) . Smooth muscle PPI and PP2A, which dephosphorylate CaP (Winder and Walsh, 1990; Fraser and Walsh, 1995) , had decreased activity in vasospasm (Fukami et aI., 1995) . Thus, the phosphorylation dephosphorylation mechanisms of MLC and CaP may play an important role in controlling smooth muscle con tractility in vasospasm. The current study examines the following questions: whether activation of tyrosine ki nase pathway in the canine basilar artery contributes to the development of vasospasm; which protein kinase is involved in MLC phosphorylation in vasospasm; and how CaP is involved in the regulation of smooth muscle contractility in vasospasm compared with vasocontrac tion induced by KCl or serotonin.
MATERIALS AND METHODS

Animal preparation
The care of the animals in this study complied with the United States Public Health Service standards. Adult mongrel dogs, each weighing 10 to 14 kg, were anesthetized with an intramuscular ketamine hydrochloride (10 mg/kg), then with intravenous pentobarbital sodium (15 mg/kg), and maintained with a 70% nitrous oxide/30% oxygen mixture. Muscle relax ation was assured with an intravenous injection of pancuronium bromide at half-hour intervals, and arterial carbon dioxide ten sion was kept at a mean of 32 ± 3 mm Hg by adjusting the respiratory pump or by adding carbon dioxide to the inspired gas. Body temperature was kept at 37°C with a heating blanket, and mean arterial blood pressure and pulse rate monitored con tinuously in the femoral artery were not changed during the procedure. Vertebral angiography was carried out through the femoral artery.
Spastic group
Cerebral vasospasm was produced in dogs by an injection of 5 mL of fresh autogenous arterial blood into the cisterna magna, followed by another injection 2 days later. Vertebral angiography was repeated 30 minutes (day 0), 2 days (day 2), and 7 days (day 7) after the first intracisternal injection of blood. The caliber of the basilar artery was measured at three predetermined levels on the magnified angiogram and was ex pressed as a percentage of the prespastic caliber. Thus, the angiogram on days 0 and 2 was obtained after the animal had received a single injection of blood, whereas that on day 7 was obtained after two injections of blood had been administered.
As control of the spastic group, 5 mL of saline was injected into the cisterna magna instead of fresh blood, and the angiographic caliber of the basilar artery was examined 2 days after the injection.
Potassium chloride and serotonin groups
The normal basilar artery was exposed by gently removing the clivus and carefully incising the dura and arachnoid under a surgical microscope. The basilar artery then was contracted 
Tissue preparation for analysis
The animals were killed after perfusion at 120 mm Hg with 500 mL of ice cold physiologic salt solution containing 140 mmollL NaCI, 4.7 mmollL KCI, 1.2 mmollL Na2HP04, 1.2 mmollL MgS04, 1.6 mmollL CaCI2, 0.02 mmollL ethylenedi amine tetraacetic acid (EDTA), 5.6 mmollL glucose, 2 mmollL 3-morpholinopropanesulfonic acid, and I mmollL sodium or thovanadate, pH 7.4, and then the basilar artery was removed together with the entire brain. In the spastic group, the blood clot around the basilar artery and its branches was carefully removed on an ice bath without any mechanical stimulation given to the arteries. After a brief washing, the basilar artery was quickly frozen in liquid nitrogen until used. The basilar arteries in the control, KCI, and serotonin groups underwent a similar procedure without the removal of the blood clot. 
Immunoprecipitation and immunoblotting analysis
FIG. 1. Immunoblot analysis by anti-phosphotyrosine antibody
shows a marked increase in phosphorylation of several intracel lular substrates of tyrosine kinase taken from the spastic basilar arteries on days 0, (0-0), 2 (0-2), and 7 (0-7). The increase in tyrosine phosphorylation observed in the spastic artery on day 7 is considerably inhibited by a topical application of 17.2 �mol/L genistein (median effective dose [EOsol for reversal of vaso spasm on day 7). Similar results were obtained in three experi ments. C, control; G, genistein. 
FIG. 2. Analysis of Shc activation showing a marked increase in
tyrosine phosphorylation of 46-, 52-, and 66-kd isoforms of Shc in the spastic basilar arteries on days 0 (0-0), 2 (0-2), and 7 (0-7).
The increase in tyrosine phosphorylation of Shc on day 7 is mark edly inhibited by a topical application of EOso of genistein. Tyro sine phosphorylation of the 66-kd isoform of Shc is scarcely de tected before vasospasm and after treatment with genistein. Bas ilar artery Iysates were immunoprecipitated with anti-Shc antibody, resolved by 10% sodium dodecylsulfate polyacrylamide gel electrophoresis (SOS-PAGE), transferred onto polyvinyl idene difluoride membranes, and immunologically probed with anti-phosphotyrosine-HRP conjugate (left). The membranes were reprobed with anti-Shc antibody, showing no significant changes in levels of 46-, 52-, and 66-kd isoforms of Shc after subarachnoid hemorrhage (SAH) and after treatment with genis tein (right). The results are from a representative study performed three times with comparable outcomes. C, control; G, genistein.
solution, the gel was dried and kinase activity was visualized using FUJIX Bio-Imaging Analyzer BAS2000 (Fuji Photo Film, Tokyo, Japan). Lysates also were probed with anti-ERKIIERK2 antibody for immunoblotting.
Response of spastic artery to genistein
After the exposed spastic basilar artery was photographed, dose-response measurements were obtained after the topical application of successively increasing concentrations of genis tein. At the end of each experiment, 4 mmollL EGTA was added. The mean diameter of spastic basilar artery was calcu lated by measurement at three predetermined levels and ex pressed as a percentage of the relaxation induced by EGT A.
The percentage relaxations (mean ± SD) induced by the in creasing concentrations of genistein were charted on logarith mic dose-response curves. The animals' mean arterial blood pressure and pulse rate were not changed significantly during the application of genistein.
Pyrophosphate polyacrylamide gel electrophoresis
The pulverized basilar artery was put in buffer (100 mmollL sodium pyrophosphate,S mmollL EGTA, 1 mmollL EDTA, 100 mmollL NaF, 10% glycerol, 2.5 mmollL DTT, 1 mmollL PMSF, pH 8.8) and centrifuged at 10,000 g for 15 minutes. The supernatant was incubated in 0.6 mollL KI for 30 minutes at 4°C, and then sucrose was added together with glycerol to adjust to final 20% sucrose solution and to pH 7.5. Polyacryl amide gel used was composed of 3.8% acrylamide, 0.101% methylenebisacrylamide, 40 mmollL Na4P207, 10% glycerol, and 15% NNN'N' -tetramethylethylenediamine, pH 8.5, and polymerized by the addition of freshly prepared 12.5% ammo nium persulphate after deaeration. Electrophoresis buffer con tained 40 mmol/L Na4P207, 10% glycerol, and 2 mmollL L cysteine, pH 8.5. After a pre-electrophoresis at II voltage/cm for 30 minutes at 2°C, the basilar artery extract was loaded on the top of gels and electrophoresed overnight under a constant voltage gradient of 8 to 11 voltage/cm using a regulated power supply. Proteins on the gels were stained with 0.1 % Coomassie brilliant blue R250.
Urea-glycerol polyacrylamide gel electrophoresis
The protein bands on PPi-PAGE were cut off separately, soaked with 9 mollL urea containing 10 mmollL Tris-HCI (pH 6.8) and 5% f3-mercaptoethanol for 8 minutes, and then sub jected to glycerol PAGE for 8 hours. Stacking gel used con- 
Phosphorylation of calponin
The pulverized basilar artery was boiled at 100°C for 5 min 
RESULTS
Caliber of the basilar artery
No significant angiographic narrowing of the basilar artery was shown before the animals in the control group were killed. The mean percent calibers in the spastic group were 78.0 ± 5.3% (P < 0.0007) on day 0, 70.2 ± 7.5% (P < 0.0009) on day 2, and 60.4 ± 6.8% (P < 0.0002) on day 7, whereas those in the KCl and serotonin groups decreased over a period of approximately 45 min utes after the treatment and then stabilized (87.4 ± 2.6% [P < 0.02] in the KCl group and 80.4 ± 1.8% (P < 0.003) in the serotonin group). Statistical significance of mean percent calibers was examined in five dogs in each group by two-tailed t test for uncorrelated pairs.
Activation of tyrosine kinase pathway
Phosphorylation of intracellular substrates of tyrosine kinase taken from the spastic basilar arteries apparently was increased in vasospasm on days 0, 2, and 7 and was markedly inhibited by a topical application of median effective dose (EDso) of genistein for reversal of vaso spasm on day 7 to the spastic basilar artery on day 7, as shown in Fig. 1 . The anti-Shc antibody specifically rec ognized the 46-, 52-, and 66-kd isoforms of Shc (Fig. 2) . When Shc immunoprecipitates were immunoblotted with anti-phosphotyrosine antibody, only 46-and 52-kd iso forms were shown to be tyrosine phosphorylated before initiation of vasospasm (52-kd isoforms were more phos phorylated than 46-kd ones). In vasospasm on days 0, 2, and 7, the phosphorylation of Shc, including the 66-kd isoform, was increased, whereas the levels of individual immunoreactive Shc isoforms were not changed, indicat ing activation of Shc. The activities of Raf l were deter mined by the presence of Raf l with reduced gel electro phoretic mobility from phosphorylation. As shown in Fig. 3 , a single immunoreactive 70-kd Rafl band became doublets after subarachnoid hemorrhage, indicating in creased phosphorylation of Raf!. Phosphorylation of ex tracellular signal-regulated kinases (ERK) was estimated by in gel myelin basic protein kinase assay. Both ERKI and ERK2 were slightly phosphorylated to similar de gree in the control group, and their phosphorylations, although ERKI phosphorylation was less than ERK2 phosphorylation, were increased after subarachnoid hem orrhage (Fig. 4) . In contrast, the immunoreactive ERKI and ERK2 levels were not changed.
Response of spastic artery to genistein
A brief washing with warm saline after careful re moval of the blood clot around the spastic basilar artery on days 0 and 7 did not induce a significant change in the caliber of the spastic basilar artery. The exposed spastic basilar artery was dilated dose-dependently by a topical application of 1 x 10-6 to 3 X 10-4 mol/L genistein. Taking the relaxation induced by 4 mmollL EGT A as 100%, the mean ± SD values of EDso of genistein for relaxation of the spastic basilar artery in three dogs were 14.0 ± 2. 1 ILmoliL on day 0 and 17.2 ± 4.5 ILmollL on day 7 (Table 1) . When the spastic basilar artery on day 7 was treated with the EDso of genistein, the phosphory- lation of intracellular substrates of tyrosine kinase (Fig.  1) , including Shc isoforms (Fig. 2) , was markedly de creased, but the immunoreactive Shc isoform levels re mained constant (Fig. 2) , indicating decrease in activities of Shc. The generation of PKM in vasospasm on days 0 and 7 detected by anti-CFa4 antibody (Sato et a!., 1997) was inhibited in response to the topical treatment with respective EDso of genistein (Fig. 5) .
Phosphorylation of myosin light chain
The phosphorylation state of MLC in the basilar artery was examined by PPi-PAGE. Four bands-designated as F, AM, AMPI, and AMP2-were detected in the spastic group on days 2 and 7, as well as in the KCI-15, KCI-90, serotonin-I5, and serotonin-90 groups (Fig. 6 ). Protein in F band showed the same mobility as did gizzard muscle filamin (Wang et a!., 1975 ) (data not shown). Since PPi PAGE in each group was performed separately, F, AM, AMPl , and AMP2 bands in each group in Fig. 6 were not arranged exactly along the same lines. To determine the extent of phosphorylation of MLC, each band on PPi PAGE was subjected to urea-glycerol PAGE, as shown representatively in the spastic arteries on day 7 in Fig. 7 . In addition to unphosphorylated 17-kd MLC, the AM band contained unphosphorylated 20-kd MLC, AMPI monophosphorylated and unphosphorylated 20-kd MLC, and AMP2 monophosphorylated 20-kd MLC. The amounts of monophosphorylated and unphosphorylated 20-kd MLC in AMPI are almost equivalent, indicating Immunoprecipitated CaP (34 kd), visualized by silver staining, is shown representatively in Fig. 8A and B, and its mean percent levels are shown in Fig. 9 . They were not changed significantly in the spastic group on day 0 or in the KCI-15, KCI-90, serotonin-15, and serotonin-90 groups, but decreased in the spastic group on days 2 and 7. The levels of phosphorylation of CaP on serine, threo nine, and tyrosine residues are shown by immunoblotting of immunoprecipitated CaP with anti-phosphoserine ( Fig. 8C and D) , ariti-phosphothreonine ( Fig. 8E and F) , and anti-phosphotyrosine antibodies ( Fig. 8G and H) , respectively. Their mean percent values of phosphoryla tion were calculated by dividing the densitometric values of phosphorylation levels of immunoprecipitated CaP on serine, threonine, and tyrosine residues by those of im munoprecipitated CaP levels visualized by silver stain ing, respectively. The mean percent levels of CaP phos phorylation on serine and threonine residues were not changed significantly in the spastic group on day 0 but increased on the spastic group on days 2 and 7 (Fig. 10) . The mean percent levels of CaP phosphorylation on ty rosine residues also were enhanced significantly in the spastic group on days 0, 2, and 7 but were not changed significantly in the KCI and serotonin groups (Fig. 10) . 
DISCUSSION
Activation of tyrosine kinase pathway in vasospasm
Increases in phosphorylation of intracellular substrates of tyrosine kinase, including Shc, Rafl , and ERK, in spastic basilar artery clearly indicate activation of the tyrosine kinase pathway. One established mechanism of receptor protein tyrosine kinase coupling involves acti vation of Ras by translocation of the Grb2-Sos complex to the plasma membrane as a consequence of its binding to an autophosphorylation site in the receptor protein tyrosine kinase itself or to substrate or adapter protein such as Shc, phosphorylated by the receptor protein ki nase (van der Geer et aI., 1994). In addition, Rafl and ERK also are activated by both Ras-dependent (Crespo et aI., 1994; van Biesen et aI., 1995) and Ras independent (van Biesen et aI., 1996) signaling pathways in response to activation of G protein-coupled receptors. The release of the (3)' subunits of heterotrimeric G pro teins after ligand binding to Gj-coupled receptors led to tyrosine phosphorylation of Shc and increased functional association of Shc, Grb2, and Sos (van Biesen et aI., 1995) . In addition, G q protein-coupled angiotensin II receptor activates the Fyn-Shc-Grb2-Sos pathway (Sa doshima and Izumo, 1996) . These data suggest that G i3'Y subunits can activate Ras using mechanisms that are similar to those used by receptor tyrosine kinase, and that Shc is implicated as a go-between that relays a message from G i3'Y -coupled receptors to protein tyrosine kinase receptors. Thus, the current results of signal transduction of tyrosine kinase pathway in vasospasm indicate that tyrosine kinase is activated by signaling from tyrosine kinase receptors, G-coupled receptors, or both. Since Rafl and ERK activation is mediated by PKC (Rapp, 1991; Thomas et aI., 1992) in addition to activation of tyrosine kinase receptors or G-coupled receptors, acti vated PKCa and PKM in vasospasm (Sato et aI., 1997) may contribute to the activation Rafl and ERK.
In addition, the spastic basilar arteries on days 0 and 7 are dilated dose-dependently by the topical application of genistein with ED50 of 14.0 ± 2. 1 j,LmollL on day 0 and 17.2 ± 4.S j,Lmol/L on day 7. The ED50 values of genistein are 2.6 to 26 j,Lmo\1L for protein tyrosine kinase of epidermal growth factor receptor and pp60NfC (Akiyama and Ogawa, 1991) . DiSalvo and others (1993) report that tyrosine kinase inhibitors such as genistein exhibit high specificity for inhibition of smooth muscle tyrosine ki nases and do not affect the activity of vascular smooth muscle MLCK or cyclic AMP-dependent protein kinase. Thus, the dilation of the spastic basilar artery by genistein does not result from the inhibition of MLCK but is closely associated with the decrease in phosphorylation of intracel lular substrates of tyrosine kinase, including Shc.
The activation of protein tyrosine kinase receptors and G protein-coupled receptors of vascular smooth muscles stimulates the hydrolysis of phosphatidylinositol 4,S bisphosphate, yielding the two second messengers ino sitol lA,S-trisphosphate (lP3) and diacylglycerol. IP3 mobilizes Ca 2 + from sequestered stores, whereas diacyl glycerol stimulates PKC. Thus, the increase in intracel lular Ca 2 + and the activation of PKC mediated by tyro sine kinase pathway are important causal events to in duce vasospasm. The mobilization of Ca 2 + from sequestered stores appears to be limited, but since the topical treatment with EGT A induces the reversal of va sospasm, the continuously increased intracellular Ca 2 + in vasospasm also may result from Ca 2 + influx in addition to the intracellular mobilization of Ca 2 +. The absence of PKM in the spastic artery after genistein treatment indi cates the inactivation of j,L-calpain, which may be in duced by the decline of intracellular Ca 2+ levels through the inhibition of tyrosine kinase pathway. The activation of Rafl and ERK in vasospasm are declined on day 7 compared with those on days 0 or 2, suggesting that the activation of tyrosine kinase pathway is more closely asso ciated with the early than with the late stage of vasospasm.
Phosphorylation of myosin light chain in vasospasm
It is generally accepted that the MLCK-catalyzed phosphorylation of MLC is a dominant regulation for the
Urea-glycerol polyacrylamide gel electrophoresis. Three bands (AM, AMP1, and AMP2) on PPi-PAGE in the spastic bas ilar artery on day 7 were cut off separately and subjected to urea-glycerol PAGE. In addition to unphosphorylated 17-kd MLG (Ld, AM is composed of un phosphorylated 20-kd MLG (L20), AMP1 of un phosphorylated (L20) and monophosphorylated (L20 P ) 20-kd MLG, and AMP2 of monophosphorylated 20-kd MLG (L20P)' The densities of L20 in AM and L20 p in AMP2 are about twice as high as L20 and L20 P in AMP1, respectively, suggesting that AM consists of homodimer of L20 and AMP2 of homodimer of L20P' Similar results were achieved in five dogs in each of spastic, KGI, and serotonin groups with comparable outcomes. were immunoprecipitated using anti-calponin antibody, resolved by 12% SOS-PAGE, and visualized with a highly sensitive silver staining, as shown in spastic group (A) and KCI and serotonin groups (B). Immunoprecipitated proteins were transferred onto PVOF membrane, and probed with anti-phosphoserine (C and D), anti-phosphothreonine (E and F), or anti-phosphotyrosine (G and H) antibody. Results are representative of independent ex periments in five dogs in each group. C, control; 0-0, vasospasm on day 0; 0-2, vasospasm on day 2; 0-7, vasospasm on day 7; K-15, vasocontraction 15 minutes after KCI treatment; K-90, va socontraction 90 minutes after KCI treatment; S-15, vasocontrac tion 15 minutes after serotonin treatment; S-90, vasocontraction 90 minutes after serotonin treatment; P-Ser, phosphorylation on serine residue; P-Thr, phosphorylation on threonine residue; P Tyr, phosphorylation on tyrosine residue. smooth muscle contraction (Kamm and Stull, 1985) . The PPi-PAGE resolves smooth muscle MLC into three bands in the MLCK-mediated phosphorylation (Takano Ohmuro et al., 1986a,b) and into a single band in the PKC-mediated phosphorylation (Trybus and Lowey, 1985) based on the phosphorylation state. These results are compatible with observations that MLCK and PKC phosphorylate smooth muscle MLC at different sites, with serine 19 and threonine 18 being the primary and the secondary residues, respectively, in MLCK-mediated phosphory lation (Ikebe and Hartshorne, 1985) , and threonine9 and serine 1 or serine2 the primary and the secondary residues, respectively, in PKC-mediated phos phorylation (Nishikawa et al., 1984; Ikebe et al., 1987) . The difference in MLCK-and PKC-specific phosphory lation sites of MLC also is compatible with the fact that phosphorylation by MLCK activates smooth muscle ac tin-activated Mg 2 +-ATPase, but phosphorylation by PKC does not (Nishikawa et al., 1984; Kamm and Stull, 1985; Ikebe et al., 1987) . When MLC is phosphorylated by MLCK and PKC, PPi-PAGE analysis shows a single band (Takano-Ohmuro and Kohama, 1987) . The current study clearly demonstrates the resolution of MLC into three bands based on the phosphorylation state in the spastic, KCl, and serotonin groups, suggesting that MLC in the three groups is phosphorylated by MLCK but not by PKC.
Biochemical analysis reveals that PKC reduces the actin-activated Mg 2 +-ATPase activity of myosin pre phosphorylated by MLCK by approximately 50% (Ike be et al., 1987; Nishikawa et al., 1984) . In addition, the PKC-catalyzed phosphorylation of MLCK decreases its activity (Ike be and Hartshorne, 1985) , suggesting that the in vitro effects of PKC-catalyzed phosphorylation of MLC and MLCK would be consistent with a relaxation rather than a contractile response. The only response of permeabilized gizzard smooth muscle in response to phosphorylation of MLC on PKC-specific residues is an attenuation of Ca 2 + -induced contraction (Sutton and Haeberle, 1990; Parente et al., 1992) . In addition, phor bol ester-induced contractions of smooth muscles are not accompanied by significant phosphorylation of MLC on the PKC-specific sites (Singer, 1990; Sutton and Hae berle, 1990) . Furthermore, contraction of intact smooth muscle fibers in response to physiologic agents that ac tivate PKC is not accompanied by MLC phosphorylation on PKC-specific sites but is accompanied by MLC phos phorylation on MLCK-specific sites (Singer, 1990) . Thus, much effort has been devoted to identifying the substrates of PKC that are involved in the contractile response, but the weight of evidence is against either MLC or MLCK being involved as substrates of PKC. The decrease in activity of smooth muscle PPI in vaso spasm (Fukami et al., 1995) probably results from acti vation of PKC (Masuo et al., 1994) and contributes to maintaining MLC phosphorylation.
Involvement of calponin in vasospasm
Several examples have been reported of an increase in CaP phosphorylation in intact smooth muscle in response to various contractile stimuli (Winder et aL, 1993; Car michael et al., 1994) , and the CaP phosphorylation dur ing contraction of porcine coronary artery induced by both endothelin-l and phorbol 12, 13-dibutyrate was first reported to be catalyzed in vivo predominantly by PKC sponse to stimuli (Baniny and Barany, 1993; Adam et aI., 1995) . There has been growing physiologic support for the role of CaP in inhibiting the actin-activated Mg 2 +_ ATPase activity of smooth muscle through its binding to actin, the phosphorylation of CaP markedly lowers the affinity of CaP for actin to alleviate inhibition of actin activated myosin Mg 2 + -ATPase activity (Ito et aI., 1995; Horowitz et aI., 1996a; Pohl et aI., 1997) , and the prop erties of CaP are restored after dephosphorylation (Winder et aI., 1992; Fraser and Walsh, 1995) . The mechanism of involvement of PKC in vasospasm re mains controversial. Membrane PKC activity has been reported to increase with a reciprocal decrease in cyto solic PKC activity (Nishizawa et aI., 1992) , that is, the activation of intact PKC. Another report shows a de crease of 40% to 45% in cytosolic PKC activity without any significant changes in membrane PKC activity, in dicating an absence of activation of intact PKC; levels of immunoreactive PKCa and PKCE but not PKC� were decreased in spastic arteries (Takuwa et aI., 1993) . We have demonstrated the activation of PKCa and the gen eration of PKM in vasospasm (Minami et aI., 1992; Sato et aI., 1997) . The activation of PKC may be induced by the diacylglycerol in the presence of the increased Ca 2 + produced by the hydrolysis of phosphatidylinositol through the activation of tyrosine kinase pathway and phosphorylate CaP in vasospasm. The current study dem onstrates that protein levels and phosphorylation levels on serine and threonine residues of CaP are not changed sig nificantly in vasospasm on day 0 or in vasocontraction induced by KCl or serotonin. On the other hand, vasospasm on days 2 and 7 is associated with a significant decrease in CaP levels (Oka et aI., 1996) and with a significant increase in CaP phosphorylation on serine and threonine residues. Both alterations are more marked in vasospasm on day 7 than on day 2 and are predicted to alleviate its inhibition of the actin-activated myosin Mg 2 +-ATPase to induce a po tential increase of smooth muscle contractility in vaso spasm. In addition, decreased activities of smooth muscle PPI and PP2A in vasospasm (Fukami et aI., 1995) may contribute further to the maintenance of CaP phosphoryla tion because PPI and PP2A dephosphorylate CaP (Winder et aI., 1992; Ichikawa et aI., 1993) . The phosphorylation of CaP on tyrosine residues, which was increased significantly in early and delayed vasospasm but not in vasocontraction induced by KCI or serotonin, may be associated with acti vation of tyrosine kinase pathway in vasospasm, but its significance is unknown.
